ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1266

Quality of Life Measures and Physical Activity in Childhood Systemic Lupus Erythematosus

Meghan Nelson1, Lori Ponder2, Sinclair Gibson3, D. Sofia Villacis- Nunez1, Lai Hin Kimi Chan3, Lakshmi Moorthy4 and Sampath Prahalad5, 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, 2Children's Healthcare of Atlanta, Atlanta, GA, 3Children’s Healthcare of Atlanta, Atlanta, GA, 4Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 5Emory + Children's Pediatric Institute, Atlanta, GA

Meeting: ACR Convergence 2021

Keywords: Health Assessment Questionnaire (HAQ), physical activity, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Outcomes (1257–1303)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Childhood systemic lupus erythematosus (cSLE) is a life-long disease with significant morbidity and mortality, and with associated significant impact on health-related quality of life (HRQOL). Prior research has shown that SLE patients’ physical activity level is lower than that of healthy individuals. Increased physical activity is associated with improved wellbeing in SLE.There is a paucity of literature examining relationship between physical activity and HRQOL in cSLE. We sought to describe the physical activity and determine the relationship between exercise, SLE activity and treatment modalities and HRQOL in cSLE. To our knowledge, this is the first study investigating the relationship between the Physical Activity Questionnaire (PAQ) and Simple Measure of the Impact of Lupus Erythematosus in Youngsters (SMILEY) total scores (both used in our study).

Methods: Children < 18 years of age with SLE and their parents were enrolled and completed corresponding child and parent SMILEY reports, and the PAQ for Children (PAQ-C) or Adolescents (PAQ-A). Through retrospective chart review we assessed disease activity (SLE Disease Activity Index). Descriptive statistics as well as Pearson’s correlation coefficients were performed with the data obtained, with the patients stratified into two cohorts of lower and higher levels of physical activity (PAQ score < 2 and ≥ 2) and based off the average PAQ score of 2, with median PAQ score of 1.8 (range 1.0- 4.7). We utilized a conservative estimate of PAQ scoring, with previous studies identifying normative PAQ scores in a healthy pediatric population ranges between a minimum of 2.7-2.9 based on age and gender, respectively.

Results: Forty-four children and their parents were enrolled; clinical data, SMILEY and PAQ-C or PAQ-A scores of cSLE subjects were evaluated. The most frequently reported exercise modality was walking (61.4%), with mean frequency of 3.7 ± 1.8 days/week, and a median of 3.5 days/week. Running was the second most frequent exercise reported (54.5%), with mean frequency of 3.1 ± 2.0 days/ week, and a median of 1.5 days/week. Our patients had an overall lower frequency of Cyclophosphamide use and higher frequency of Mycophenolate and Rituximab use. Patients with hypocomplementemia at diagnosis, current prednisone use, Class IV/V lupus nephritis, and Cyclophosphamide use had a higher proclivity towards less activity (PAQ score < 2). There was a mild correlation between SMILEY total score and PAQ [cSMILEY and PAQ (Pearson correlation=0.2), and pSMILEY scores (Pearson correlation=0.3;p=0.05)]. cSLE patients with PAQ≥ 2 had higher child and parent SMILEY scores but the difference was not statistically significant. There was a strong correlation between child and parent-SMILEY scores (Pearson correlation=0.7;p= < .00001).

Conclusion: Patients with cSLE prefer walking followed by running. cSLE patients with higher physical activity appeared to have better HRQOL, lower steroid use, and less cyclophosphamide use. We need larger samples to understand the prognostic value of activity levels and the extent to which increasing physical activity through exercise might be linked to improvements in HRQOL in this vulnerable population.

Table 1: Characteristics of SMILEY Participants stratified by PAQ scores. This table depicts the patient demographics, clinical features and management of enrolled pediatric systemic lupus erythematosus patients for patients with PAQ scores < 2 and ≥2.


Disclosures: M. Nelson, None; L. Ponder, None; S. Gibson, None; D. Villacis- Nunez, None; L. Chan, None; L. Moorthy, Bristol Myer Squibb, 5; S. Prahalad, Novartis, 1.

To cite this abstract in AMA style:

Nelson M, Ponder L, Gibson S, Villacis- Nunez D, Chan L, Moorthy L, Prahalad S. Quality of Life Measures and Physical Activity in Childhood Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/quality-of-life-measures-and-physical-activity-in-childhood-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-life-measures-and-physical-activity-in-childhood-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology